Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Emory University
Ohio State University
Endeavor Biomedicines, Inc.
Replimune Inc.
M.D. Anderson Cancer Center
Linnaeus Therapeutics, Inc.
TScan Therapeutics, Inc.
Novelty Nobility, Inc.